#40 – Breakpoints Talks Breakpoints: Microbiology Labs and Stewardship
Breakpoints
00:00
The Uncomplicated vs. Complexed UTI
The FDA and seal aside break points for Keflex have not been updated. "It took a lot of like brain power to come up with the right solution," says Dr. John Rizzo, chief executive officer of Janssen Pharmaceuticals. The company is also trying to figure out what type of UTI patients should be covered by its drug.
Transcript
Play full episode
